Stereotaxis Statistics
Total Valuation
Stereotaxis has a market cap or net worth of $195.47 million. The enterprise value is $180.39 million.
| Market Cap | 195.47M |
| Enterprise Value | 180.39M |
Important Dates
The next confirmed earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Stereotaxis has 82.13 million shares outstanding. The number of shares has increased by 6.10% in one year.
| Shares Outstanding | 82.13M |
| Shares Change (YoY) | +6.10% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 15.87% |
| Owned by Institutions (%) | 47.52% |
| Float | 58.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.30 |
| Forward PS | 6.27 |
| PB Ratio | 11.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.51 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -110.10% and return on invested capital (ROIC) is -100.03%.
| Return on Equity (ROE) | -110.10% |
| Return on Assets (ROA) | -47.60% |
| Return on Capital (ROIC) | -100.03% |
| Revenue Per Employee | $219,434 |
| Profits Per Employee | -$180,787 |
| Employee Count | 122 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.23% in the last 52 weeks. The beta is 1.34, so Stereotaxis's price volatility has been higher than the market average.
| Beta (1Y) | 1.34 |
| 52-Week Price Change | +35.23% |
| 50-Day Moving Average | 2.70 |
| 200-Day Moving Average | 1.95 |
| Relative Strength Index (RSI) | 38.08 |
| Average Volume (30 Days) | 309,156 |
Short Selling Information
The latest short interest is 925,386, so 1.13% of the outstanding shares have been sold short.
| Short Interest | 925,386 |
| Short Previous Month | 819,817 |
| Short % of Shares Out | 1.13% |
| Short % of Float | 1.58% |
| Short Ratio (days to cover) | 3.73 |
Income Statement
In the last 12 months, Stereotaxis had revenue of $26.77 million and -$22.06 million in losses. Loss per share was -$0.27.
| Revenue | 26.77M |
| Gross Profit | 14.86M |
| Operating Income | -21.84M |
| Pretax Income | -20.71M |
| Net Income | -22.06M |
| EBITDA | -20.09M |
| EBIT | -20.71M |
| Loss Per Share | -$0.27 |
Balance Sheet
The company has $20.56 million in cash and $5.49 million in debt, giving a net cash position of $15.07 million or $0.18 per share.
| Cash & Cash Equivalents | 20.56M |
| Total Debt | 5.49M |
| Net Cash | 15.07M |
| Net Cash Per Share | $0.18 |
| Equity / Book Value | 16.34M |
| Book Value Per Share | 0.20 |
| Working Capital | 20.02M |
Cash Flow
In the last 12 months, operating cash flow was -$9.14 million and capital expenditures -$366,000, giving a free cash flow of -$9.51 million.
| Operating Cash Flow | -9.14M |
| Capital Expenditures | -366,000 |
| Free Cash Flow | -9.51M |
| FCF Per Share | -$0.12 |
Margins
Gross margin is 55.51%, with operating and profit margins of -81.58% and -82.39%.
| Gross Margin | 55.51% |
| Operating Margin | -81.58% |
| Pretax Margin | -77.37% |
| Profit Margin | -82.39% |
| EBITDA Margin | -75.03% |
| EBIT Margin | -77.37% |
| FCF Margin | -35.50% |
Dividends & Yields
Stereotaxis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.10% |
| Shareholder Yield | -6.10% |
| Earnings Yield | -11.28% |
| FCF Yield | -4.86% |
Analyst Forecast
The average price target for Stereotaxis is $4.50, which is 89.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 89.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 4, 2013. It was a forward split with a ratio of 1096:1000.
| Last Split Date | Nov 4, 2013 |
| Split Type | Forward |
| Split Ratio | 1096:1000 |
Scores
Stereotaxis has an Altman Z-Score of -12.51 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.51 |
| Piotroski F-Score | 3 |